Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antibody COVID-19”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06968442
What this trial is testing

The Role of Obesity in Severe COVID-19 Pathophysiology

Who this might be right for
COVID-19Antibody COVID-19
Franciscus Gasthuis 60
Not applicableNo Longer AvailableNCT04802083
What this trial is testing

COVID-19 Soliris Expanded Access Protocol

Who this might be right for
Covid19
Alexion Pharmaceuticals, Inc.
Not applicableStudy completedNCT04389294
What this trial is testing

HSS Covid-19 Antibody Serology Among Surgeons & Anesthesiologists

Who this might be right for
COVID
Hospital for Special Surgery, New York 143
Not applicableStudy completedNCT04471051
What this trial is testing

An Observational Cohort Trial of Outcomes and Antibody Responses Following Treatment With COVID19 Convalescent Plasma in Hospitalized COVID-19 Patients

Who this might be right for
Covid19
University of Colorado, Denver 255
Not applicableStudy completedNCT04734886
What this trial is testing

The Effect of Probiotic Supplementation on SARS-CoV-2 Antibody Response After COVID-19

Who this might be right for
Covid19
Örebro University, Sweden 161
Not applicableEnded earlyNCT05315583
What this trial is testing

Neutralizing Power of Anti-SARS-CoV-2 (Anti-COVID-19) Serum Antibodies

Who this might be right for
COVID-19SARS CoV 2 Infection
Centre Hospitalier Régional d'Orléans 9
Testing effectiveness (Phase 2)Study completedNCT05077254
What this trial is testing

COVID Protection After Transplant-Immunosuppression Reduction

Who this might be right for
Kidney Transplant RecipientsLiver Transplant Recipients
National Institute of Allergy and Infectious Diseases (NIAID) 48
Not applicableUnknownNCT04526977
What this trial is testing

Differences in Immune Response Among HIV-1-infected Individuals With Previous or Current COVID-19 (CoVIHDis).

Who this might be right for
Covid19Immune SuppressionHIV-1-infection
Asociacion para el Estudio de las Enfermedades Infecciosas 90
Not applicableUnknownNCT04445415
What this trial is testing

Diagnostic Value of New COVID-19 Antibodies Testing Among Laboratory Healthcare Workers

Who this might be right for
COVID-19
Assiut University 250
Not applicableStudy completedNCT05067400
What this trial is testing

SARS-CoV-2 (COVID-19) Antibody PrevalencE in an Adult London HIV Cohort

Who this might be right for
HIV-1-infectionSARS-CoV InfectionCovid19
Royal Free Hospital NHS Foundation Trust 615
Testing effectiveness (Phase 2)Ended earlyNCT04992273
What this trial is testing

COVID-19 Administration of Single-Dose Subcutaneous Anti- Spike(s) SARS-CoV-2 Monoclonal Antibodies Casirivimab and Imdevimab in High-Risk Pediatric Participants Under 12 Years of Age

Who this might be right for
COVID-19
Regeneron Pharmaceuticals 7
Not applicableUnknownNCT04678024
What this trial is testing

Sensitivity Evaluation of Serological Tests for Covid-19

Who this might be right for
Covid19
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio 410
Testing effectiveness (Phase 2)WithdrawnNCT05465876
What this trial is testing

Passive Antibodies Against COVID-19 With EVUSHELD in Vaccine Non-responsive CLL

Who this might be right for
Chronic Lymphocytic LeukemiaCOVID-19
Sunnybrook Health Sciences Centre
Large-scale testing (Phase 3)Ended earlyNCT05205759
What this trial is testing

Non-inferiority Trial on Monoclonal Antibodies in COVID-19

Who this might be right for
COVID-19
Azienda Ospedaliera Universitaria Integrata Verona 319
Testing effectiveness (Phase 2)Study completedNCT04480424
What this trial is testing

Study to Evaluate the Safety and Efficacy of High Dose Intravenous Immune Globulin (IVIG) Plus Standard Medical Treatment (SMT) Versus SMT Alone in Participants in Intensive Care Unit (ICU) With Coronavirus Disease (COVID-19)

Who this might be right for
COVID-19
Grifols Therapeutics LLC 100
Not applicableStudy completedNCT04453280
What this trial is testing

Antibody Detection in COVID-19 Cured Patients (SARS-CoV-2-CZ-Immunity)

Who this might be right for
COVIDSARS-CoV-2
Institute of Health Information and Statistics of the Czech Republic 695
Not applicableStudy completedNCT05313048
What this trial is testing

Prospective Observational Study to Evaluate a Possible Change in APS Antibody Profiles After COVID-19 Infection or Vaccination

Who this might be right for
Antiphospholipid SyndromeCOVID-19 InfectionCOVID-19 Vaccination
Cardioangiologisches Centrum Bethanien 82
Not applicableStudy completedNCT04525417
What this trial is testing

Rapid Screening Test for Covid-19 Antibodies in Healthcare Workers

Who this might be right for
Covid-19 Immune Status of Healthcare Workers
Groupe d'Etude sur le Risque d'Exposition des Soignants aux Agents Infectieux 75
Not applicableEnded earlyNCT04346589
What this trial is testing

Convalescent Antibodies Infusion in Critically Ill COVID 19 Patients

Who this might be right for
Pneumonia, Ventilator-AssociatedCoronavirus Infection
A.O. Ospedale Papa Giovanni XXIII 9
Not applicableStudy completedNCT04472078
What this trial is testing

Seroprevalence of Coronavirus Disease 2019 (COVID-19) Antibodies in a Vulnerable Neighbourhood, Buenos Aries Argentina

Who this might be right for
SARS-CoV-2
Hospital Italiano de Buenos Aires 873
Next Page